Sign in

CIK 0001750284 · Non-accelerated filer<br>Smaller reporting company

Olema Oncology, Inc.

Sign in to watch
Ticker
OLMA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
300409740
Phone
(415) 651-3316
Business address
365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Former names
Olema Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 17 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-03-10 Horn Kinney CHIEF BUSINESS OFFICER Option exercise · Stock Option (Right to Buy) −5,253 141,785
2022-02-10 Horn Kinney CHIEF BUSINESS OFFICER Option exercise +5,251 $2.06 $11K 7,709
2022-02-10 Horn Kinney CHIEF BUSINESS OFFICER Returned to the company −5,251 2,458
2022-02-10 Horn Kinney CHIEF BUSINESS OFFICER Option exercise · Stock Option (Right to Buy) −5,251 147,038
2022-02-01 Myles David C. CHIEF DEVELOPMENT OFFICER Grant or award · Stock Option (Right to Buy) +118,750 118,750
2022-02-01 Kushner Peter J. CHIEF SCIENTIFIC OFFICER Grant or award · Stock Option (Right to Buy) +61,750 61,750
2022-02-01 Harmon Cyrus CHIEF TECHNOLOGY OFFICER Grant or award · Stock Option (Right to Buy) +104,500 104,500
2022-02-01 Horn Kinney CHIEF BUSINESS OFFICER Grant or award · Stock Option (Right to Buy) +133,000 133,000
2022-02-01 Moriarty John B EVP, CH. LEGAL OFFICER & SEC. Grant or award · Stock Option (Right to Buy) +166,250 166,250
2022-02-01 Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. Grant or award · Stock Option (Right to Buy) +247,000 247,000
2022-02-01 Bohen Sean PRESIDENT AND CEO Grant or award · Stock Option (Right to Buy) +812,250 812,250
2022-02-01 Zojwalla Naseem CHIEF MEDICAL OFFICER Grant or award · Stock Option (Right to Buy) +250,000 250,000
2022-01-10 Horn Kinney CHIEF BUSINESS OFFICER Option exercise +5,251 $2.06 $11K 7,709
2022-01-10 Horn Kinney CHIEF BUSINESS OFFICER Sale −5,251 $6.85 $36K 2,458
2022-01-10 Horn Kinney CHIEF BUSINESS OFFICER Option exercise · Stock Option (Right to Buy) −5,251 152,289
2021-12-10 Horn Kinney CHIEF BUSINESS OFFICER Option exercise +5,251 $2.06 $11K 7,709
2021-12-10 Horn Kinney CHIEF BUSINESS OFFICER Sale −5,251 $10.39 $55K 2,458
2021-12-10 Horn Kinney CHIEF BUSINESS OFFICER Option exercise · Stock Option (Right to Buy) −5,251 157,540
2021-12-10 Myles David C. CHIEF DEVELOPMENT OFFICER Sale −10,000 $10.30 $103K 582,901
2021-11-30 BVF PARTNERS L P/IL Director Purchase +362,430 $9.39 $3.4M 3,755,093

Page 15 of 21 · 402 trades